Sponsor:
Malamo Countouris
Code:
NCT06281665
Conditions
Hypertensive Disorder of Pregnancy
Pre-Eclampsia
Hypertension
Eclampsia
Gestational Hypertension
Eligibility Criteria
Sex: Female
Age: 18 - 55
Healthy Volunteers: Not accepted
Interventions
Low-dose aspirin
Placebo
Brief summary:
Conditions
Hypertensive Disorder of Pregnancy
Pre-Eclampsia
Hypertension
Eclampsia
Gestational Hypertension
Study ID
NCT06281665
Start date
May 29, 2024
Status verified date
Jun, 2026
Completion date
Sep 1, 2027
Anticipated
Primary completion date
Sep 1, 2026
Anticipated
Eligibility Criteria
Sex: Female
Age: 18 - 55
Healthy Volunteers: Not accepted
Enrollment
60 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Other
Arms
placebo comparator: Placebo Group
experimental: Intervention Group
Interventions
Low-dose aspirin
Placebo
Primary outcome measure
Central contacts
Locations
University of Pittsburgh Magee-Womens Hospital
Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contacts
Principal Investigator:
Alisse K Hauspurg, MD
Sponsor
Malamo Countouris
Last update posted
Jun 4, 2026
Last verified
Jun, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Malamo Countouris on 2026-06-04.